Race, response to chemotherapy, and outcome within clinical breast cancer subtypes

JR Tichy, AM Deal, CK Anders… - Breast cancer research …, 2015 - Springer
The effect of race on breast cancer outcome is confounded by tumor and treatment
heterogeneity. We examined a cohort of women with stage II–III breast cancer treated …

Racial disparities in breast cancer persist despite early detection: analysis of treatment of stage 1 breast cancer and effect of insurance status on disparities

EJ Hoppe, LR Hussain, KJ Grannan… - Breast Cancer Research …, 2019 - Springer
Purpose Prior research demonstrates racial disparities in breast cancer treatment.
Disparities are commonly attributed to more advanced stage at presentation or aggressive …

Race and delays in breast cancer treatment across the care continuum in the Carolina Breast Cancer Study

KE Reeder‐Hayes, SE Mayer, AF Olshan… - Cancer, 2019 - Wiley Online Library
Background After controlling for baseline disease factors, researchers have found that black
women have worse breast cancer survival, and this suggests that treatment differences may …

Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897

DL Hershman, JM Unger, WE Barlow… - Journal of Clinical …, 2009 - ascopubs.org
Purpose Women of African ancestry (AA) have lower WBC counts and are more likely to
have treatment delays and discontinue adjuvant breast cancer therapy early compared with …

Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer

JM Pastoriza, GS Karagiannis, J Lin… - Clinical & experimental …, 2018 - Springer
Black race compared to white race is associated with more advanced stage and biologically
aggressive breast cancer. Consequently, black patients are more frequently treated with …

Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node‐positive, operable breast cancer

A Bhargava, XL Du - Cancer, 2009 - Wiley Online Library
BACKGROUND: Consistent with findings from clinical trials, a recent population‐based
study indicated that adjuvant chemotherapy for lymph node‐positive, operable breast cancer …

The influence of black race on treatment and mortality for early-stage breast cancer

JPB Berz, K Johnston, B Backus, G Doros, AJ Rose… - Medical care, 2009 - journals.lww.com
Background: Black Americans have higher mortality from breast cancer than white
Americans. This study explores the influence of socioeconomic factors and black race on …

Racial disparities in breast cancer survival after treatment initiation in Brazil: a nationwide cohort study

LLP Lemos, MC Souza, AA Guerra, T Piazza… - The Lancet Global …, 2024 - thelancet.com
Background Breast cancer is a public health priority in Brazil and ensuring equity in health
care is one of the cancer control plan goals. Our aim was to present the first assessment on …

Racial differences in the use and outcome of neoadjuvant chemotherapy for breast cancer: results from the National Cancer Data Base

BK Killelea, VQ Yang, SY Wang, B Hayse… - Journal of Clinical …, 2015 - ascopubs.org
Purpose To explore racial differences in the use and outcome of neoadjuvant chemotherapy
for breast cancer. Methods The National Cancer Data Base was queried to identify women …

African‐American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin‐based chemotherapy

WA Woodward, EH Huang… - … Journal of the …, 2006 - Wiley Online Library
Abstract BACKGROUND. African‐American (AA) race has been associated with a worse
outcome in breast cancer. It is unclear whether this is due to biological factors …